1.Analyzing the prevalence of key occupational hazards in 56 printing enterprises in Shenzhen City
LIAO Jing TAN Cheng long YU Bi kun
China Occupational Medicine 2022;49(05):596-
		                        		
		                        			
		                        			 Objective
To investigate the prevalence of the occupational hazard of organic solvent and noise in printing and
Methods
record medium production enterprises in Longgang District of Shenzhen City. A total of 56 printing and record
medium production enterprises were selected as the study subjects by judgmental sampling method to analyze the worksite
Results
survey of occupational health and the key occupational hazard factors. There were 256 organic solvent samples
,
detected in 56 enterprises which included a total of 148 terms and 1 358 categories of volatile constituents. The top three
( ), - ( ) ( )
volatile constituents were toluene 35.5% n hexane 25.7% and methanol 23.8% . The top three detected samples of the
( , , , , - , ,- ,
eight key chemical occupational hazard factors benzene toluene xylene ethylbenzene n hexane 1 2 dichloroethane
) , - ,
trichloroethylene and chloroform were toluene n hexane and ethylbenzene. In the workplace air toluene was the most risk
,
factor of occupational hazard factors in enterprise and in sample detection while no trichloromethane was detected. The toluene
in workplace air was found to exceed the national standard with the rate of 2.6%. It showed that 27.9% of the work sites were
found occupational noise hazard which was over national standard in the 10 key work sites. Only 64.3% and 57.1% enterprises
-
performed occupational hazard factors detection and occupational health examination. Both none or invalid toxicant proof
-
facilities accounted for 33.9% of the enterprises. Both none or invalid noise proof facilities accounted for 78.6% of the
Conclusion , -
enterprises. The occupational hazards factor of toluene n hexane and noise were serious in printing and record
,
medium production enterprises in Longgang District of Shenzhen City and the occupational health management was imperfect.
The occupational regulation should be enhanced in this industry.
		                        		
		                        		
		                        		
		                        	
2.Endovascular abdominal aortic aneurysm repair with a new stent graft:early results from a multicenter study.
Hong Peng ZHANG ; Xi Wei ZHANG ; Xiang Chen DAI ; Min TIAN ; Bin YANG ; Zhi Wei WANG ; Xiao Jun SHU ; Yu Hong CHEN ; Jian Jun JIANG ; Jian Hua HUANG ; Chang SHU ; Xiao QIN ; Xin Wu LU ; Hong Kun ZHANG ; Wei BI ; Yong LIU ; Bing CHEN ; Zhi Peng HU ; Jian ZUO ; Ping Fan GUO ; Jun LUO ; Xini Yuan TONG ; Wei GUO
Chinese Journal of Surgery 2022;60(12):1049-1056
		                        		
		                        			
		                        			Objective: To examine the safety and effectiveness of a new stent graft system for endovascular repair of abdominal aortic aneurysm(AAA). Methods: This is a prospective,multi-center,single-arm clinical trial. The patients with AAA treated with a new stent graft system were enrolled at 21 centers from September 2018 to September 2019 in China. Follow-up was performed before discharge, and at 30, 180, 360 days after operation, respectively. The primary safety endpoint was the incidence of major adverse events(MAE) within 30 days. The primary efficacy endpoint was the success rate of AAA treatment at 360 days. Secondary safety endpoints were the incidence of perioperative access complications and acute lower limb ischemia,all-cause mortality, AAA related mortality and incidence of serious adverse events (SAE) at 180 and 360 days. Secondary efficacy endpoints were the incidence of type Ⅰ or Ⅲ endoleak,stent displacement,and conversion to open surgery or re-intervention at 180 and 360 days. Results: One hundred and fifty-six patients were enrolled,including 137 males and 19 females. The age was (68.9±6.9) years (range:48.2 to 84.6 years).Maximum aneurysm diameter was (50.8±11.2) mm (range:25.0 to 85.0 mm),diameter of proximal landing zone was (21.2±2.5) mm (range:17.0 to 29.5 mm),and length of proximal landing zone was (31.4±13.0) mm (range:11.0 to 75.0 mm).The incidence of MAE was 1.3% (2/156) at 30 days,both were all-cause death cases. The success rate of AAA treatment was 88.5% (138/156) at 360 days. No perioperative access complication and acute lower limb ischemia occurred. All-cause mortality was 2.0% (3/154) at 180 days and 2.6% (4/153) at 360 days,and there was no AAA related death. The incidence of SAE was 23.0%(35/152) at 180 days and 30.5%(46/151) at 360 days, and no device-related SAE occurred. The incidence of type Ⅰor Ⅲ endoleak was 3.4% (5/147) at 180 days and 3.5% (5/144) at 360 days. Conclusion: The new stent graft system is easy to operate,and early-term safety and effectiveness results are expected.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Aged, 80 and over
		                        			;
		                        		
		                        			Prospective Studies
		                        			;
		                        		
		                        			China
		                        			;
		                        		
		                        			Ischemia
		                        			;
		                        		
		                        			Aortic Aneurysm, Abdominal/surgery*
		                        			
		                        		
		                        	
3.Identification of potential Q-markers of Semen Armeniacae Amarum based on UPLC-MS/MS and metabonomics
Yao CHENG ; Yue-lin BI ; Xin FENG ; Jia-qi WANG ; Hao-ran XU ; Tong-hua ZHANG ; Geng-yuan YU ; Chen-ning ZHANG ; Jing-hong WANG ; Yi-kun SUN
Acta Pharmaceutica Sinica 2022;57(10):3195-3202
		                        		
		                        			
		                        			 Bitter almonds (Semen Armeniacae Amarum) are prone to oil deterioration during storage, so they often require mashing prior to clinical use. To confirm the medical value of bitter almonds "being mashed when used" and to determine the optimal storage conditions for bitter almonds, UPLC-MS/MS was used to perform a comparative study of the chemical composition of bitter almonds in different storage states (mashed and unmashed), storage times (0, 2 and 4 weeks), and storage temperatures (25 ℃ and 4 ℃). A total of 58 substances were identified in bitter almond extracts through literature review, this group's previous work, and a Compound Discoverer software search. Statistically significant differences were found in the chemical composition and content of bitter almonds in different storage states, storage times, and storage temperatures. The results show that the chemical composition of bitter almonds stored unmashed was more stable than that of bitter almonds stored mashed; the chemical composition of bitter almonds stored at 4 ℃ was more stable than that of bitter almonds stored at 25 ℃; and the shorter the storage time, the less the chemical composition changed. Amygdalin, the main medicinal component of bitter almonds, showed statistically significant differences in content under the above three storage conditions, which can be used as a potential quality marker for bitter almonds. 
		                        		
		                        		
		                        		
		                        	
4.Stereotactic body radiation therapy for patients with lung and liver oligometastases from colorectal cancer: a phase Ⅱ trial.
Jun Qin LEI ; Wen Yang LIU ; Yuan TANG ; Yu TANG ; Ning LI ; Hua REN ; Chi YIHEBALI ; Yong Kun SUN ; Wen ZHANG ; Xin Yu BI ; Jian Jun ZHAO ; Hui FANG ; Ning Ning LU ; Ai Ping ZHOU ; Shu Lian WANG ; Yong Wen SONG ; Yue Ping LIU ; Bo CHEN ; Shu Nan QI ; Jian Qiang CAI ; Ye Xiong LI ; Jing JIN
Chinese Journal of Oncology 2022;44(3):282-290
		                        		
		                        			
		                        			Objective: To explore the safety and effectiveness of stereotactic body radiation therapy (SBRT) for oligometastases from colorectal cancer (CRC). Methods: This is a prospective, single-arm phase Ⅱ trial. Patients who had histologically proven CRC, 1 to 5 detectable liver or lung metastatic lesions with maximum diameter of any metastases ≤5 cm were eligible. SBRT was delivered to all lesions. The primary endpoint was 3-year local control (LC). The secondary endpoints were treatment-related acute toxicities of grade 3 and above, 1-year and 3-year overall survival (OS) and progression free survival (PFS). Survival analysis was performed using the Kaplan-Meier method and Log rank test. Results: Petients from 2016 to 2019 who were treated in Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. Forty-eight patients with 60 lesions were enrolled, including 37 liver lesions and 23 lung lesions. Forty-six patients had 1 or 2 lesions, with median diameter of 1.3 cm, the median biologically effective dose (BED(10)) was 100.0 Gy. The median follow-up was 19.5 months for all lesions. Twenty-five lesions developed local failure, the median local progression free survival was 15 months. The 1-year LC, OS and PFS was 70.2% (95% CI, 63.7%~76.7%), 89.0% (95% CI, 84.3%~93.7%) and 40.4% (95%CI, 33.0%~47.8%). The univariate analysis revealed that planning target volume (PTV) and total dose were independent prognostic factors of LC (P<0.05). For liver and lung lesions, the 1-year LC, OS and PFS was 58.7% and 89.4% (P=0.015), 89.3% and 86.5% (P=0.732), 30.5% and 65.6% (P=0.024), respectively. No patients developed acute toxicity of grade 3 and above. Conclusion: SBRT is safe and effective treatment method for oligometastases from CRC under precise respiratory motion management and robust quality assurance.
		                        		
		                        		
		                        		
		                        			Colorectal Neoplasms
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Liver/pathology*
		                        			;
		                        		
		                        			Lung/pathology*
		                        			;
		                        		
		                        			Prospective Studies
		                        			;
		                        		
		                        			Radiosurgery/methods*
		                        			
		                        		
		                        	
5. Hypoglycemic effects of Tibetan medicine Huidouba in STZ-induced diabetic mice and db/db mice
Ying-hui BAI ; Dong-xu SHI ; Hong-yu LU ; Kun-bao YANG ; Huan-hu ZHAO ; Bi-nan LU ; Zong-ran PANG ; Ying-hui BAI ; Dong-xu SHI ; Hong-yu LU ; Kun-bao YANG ; Huan-hu ZHAO ; Bi-nan LU ; Zong-ran PANG ; Kun-bao YANG
Chinese Herbal Medicines 2021;13(2):202-209
		                        		
		                        			
		                        			 Objective: Huidouba (HDB) is a Chinese folk medicine used to treat diabetes in Sichuan Province, China. Therefore, we investigated the anti-diabetic effects of HDB and its underlying mechanisms. We hypothesized that HDB treatment could enhance glucose tolerance and insulin sensitivity, and thus prevent a hyperglycemia state. Methods: To test the hypothesis, streptozotocin (STZ)-induced diabetic mice and db/db mice, widely used models of hyperglycemia and insulin-resistant diabetes, were either treated with HDB, metformin, or acarbose. Blood glucose, oral glucose tolerance test, insulin tolerance test, pancreatic histopathology and serum biochemistry were detected to assess the hypoglycemic effect of HDB. Results: HDB treatments were found to show the effect in reducing glucose levels. HDB also resulted in a significant reduction in body weight and food intake in the STZ-induced diabetic mouse model. Furthermore, it significantly improved glucose and insulin tolerance in the two diabetic mouse models. Importantly, insulin, glucagon, pancreatic polypeptide, and somatostatin immunohistochemistry revealed that HDB treatment improved the function and the location of the cells in the islets compared with the other two treatments. HDB treatment resulted in significant restoration of islet function. Our results illustrated the underlying mechanism of HDB in the progression of diabetes, and HDB can be an effective agent for the treatment of diabetes. Conclusion: The results of this study suggested that HDB can reduce blood glucose levels in STZ-induced hyperglycemic mice and db/db mice. 
		                        		
		                        		
		                        		
		                        	
6.Performance of a recombinase - aided amplification assay for detection of Schistosoma japonicum infections in Oncomelania hupensis
Yu-Ying YE ; Song ZHAO ; Yan-Hong LIU ; Nian-Nian BI ; Xuan DONG ; Chun-Rong XIONG ; Hong-Ru ZHU ; Feng TANG ; Xin-Yao WANG ; Jian-Feng ZHANG ; Qing-Jie YING ; Kun YANG
Chinese Journal of Schistosomiasis Control 2021;33(2):185-188
		                        		
		                        			
		                        			 Objective To evaluate the efficiency of a recombinase-aided amplification (RAA) assay for the detection of Schistosoma japonicum infections in Oncomelania hupensis snails. Methods A group test was employed. Fifty Oncomelania snails were collected as a detection sample. The detection samples without infected snails were designated as negative specimens, while the detection samples that contained different numbers of infected snails were designated as positive specimens. A total of 10 negative specimens, 10 positive specimens containing 1 infected snail, 20 positive specimens containing 2 infected snails and 10 positive specimens containing 3 infected snails were assigned. Following random grouping, 40 specimens were subject to the florescent RAA assay using a blind method. The miradium shedding method served as a gold standard, and the sensitivity, specificity, Youden’s index and coincidence rate of the florescent RAA assay were estimated. In addition, 20 samples consisted of 5 negative specimens and 15 positive specimens with 1, 2 and 3 infected snails respectively were grouped randomly. The same specimens were detected using the crushing method and fluorescent RAA assay with the blind method in a paired-design manner. Then, the test results were compared and analyzed. Results Florescent RAA assay detected 29 positives in the 30 specimens containing different numbers of infected snails, with a sensitivity of 96.67%, and 8 negatives in the 10 detection specimens without infected snails, with a specificity of 80.00%, showing a Youden’s index of 0.77. The coincidence rate was 100% among 10 repeated assays for a detection specimen. In addition, there was no significant difference in the detection of infected snails between the florescent RAA assay and the crushing method (χ2 = 0, P > 0.05), and the actual coincidence rates of the florescent RAA assay and crushing method were 95.00% (19/20) and 90.00% (18/20) with the real results, respectively. Conclusion Fluorescent RAA assay has a favorable efficiency for the detection of S. japonicum infections in Oncomelania snails, which shows a potential in screening of S. japonicum-infected Oncomelania snails. 
		                        		
		                        		
		                        		
		                        	
8.Huidouba Ameliorates Kidney Oxidative Stress Injury by Down-regulating Nox4 Expression in Rats with Diabetic Nephropathy
Kun-bao YANG ; Zong-ran PANG ; Ying-hui BAI ; Bi-nan LU ; Ning YU ; Gui-yan HAN ; Chang-jiang YIN
Chinese Journal of Experimental Traditional Medical Formulae 2020;26(18):84-90
		                        		
		                        			
		                        			Objective:From a new perspective,to explore therapeutic effect of Huidouba (HDB) on alleviating kidney oxidative damage in rats with diabetic nephropathy (DN) and provide a scientific basis for developing HDB as a potential Tibetan medicine for treatment of DN. Method:Rats were fed with high-fat diet (HFD) and injected with streptozocin (STZ, 65 mg·kg-1) intraperitoneally to induce DN model, while rats in Blank group were injected with an equal volume of vehicle and fed with normal chow. The successfully modeling DN rats were randomly divided into three groups, 8 rats per group, DN model group (10 mL·kg-1·d-1), Metformin group (0.045 g·kg-1·d-1) and HDB group (0.18 g·kg-1·d-1). Monitor body weight (BW) and fasting blood glucose (FBG) weekly, and collect 24 hours urine before and after medication to examine microalbuminuria (mAlb). Calculate kidney index (KI) after sacrificing, analyze mAlb, serum creatinine (SCr) and blood urea nitrogen (BUN) with a fully automatic biochemical analyzer. Histopathology of kidney was observed by Masson staining. Lipid peroxidation malondialdehyde (MDA) assay kit was used to examine MDA content in kidney tissue. Nox4, as a subtype of triphosphopyridine nucleotide (NADPH) oxidase family was determined by Western blot and immunofluorescence assay of kidney tissue. Result:Compared with blank group, levels of FBG, 24 h mAlb, SCr, BUN and MDA in DN model group were increased (
		                        		
		                        	
9.Activated mTOR signaling pathway in myofibers with inherited metabolic defect might be an evidence for mTOR inhibition therapies.
Jing-Wei LYU ; Xue-Bi XU ; Kun-Qian JI ; Na ZHANG ; Yuan SUN ; Dan-Dan ZHAO ; Yu-Ying ZHAO ; Chuan-Zhu YAN
Chinese Medical Journal 2019;132(7):805-810
		                        		
		                        			BACKGROUND:
		                        			Abnormally activated mechanistic target of rapamycin (mTOR) pathway has been reported in several model animals with inherited metabolic myopathies (IMMs). However, the profiles of mTOR pathway in skeletal muscles from patients are still unknown. This study aimed to analyze the activity of mTOR pathway in IMMs muscles.
		                        		
		                        			METHODS:
		                        			We collected muscle samples from 25 patients with mitochondrial myopathy (MM), lipid storage disease (LSD) or Pompe disease (PD). To evaluate the activity of mTOR pathway in muscle specimens, phosphorylation of S6 ribosomal protein (p-S6) and p70S6 kinase (p-p70S6K) were analyzed by Western blotting and immunohistochemistry.
		                        		
		                        			RESULTS:
		                        			Western blotting results showed that p-p70S6K/p70S6K in muscles from LSD and MM was up-regulated when compared with normal controls (NC) (NC vs. LSD, U = 2.000, P = 0.024; NC vs. MM: U = 6.000, P = 0.043). Likewise, p-S6/S6 was also up-regulated in muscles from all three subgroups of IMMs (NC vs. LSD, U = 0.000, P = 0.006; NC vs. PD, U = 0.000, P = 0.006; NC vs. MM, U = 1.000, P = 0.007). Immunohistochemical study revealed that p-S6 was mainly expressed in fibers with metabolic defect. In MM muscles, most p-S6 positive fibers showed cytochrome C oxidase (COX) deficiency (U = 5.000, P = 0.001). In LSD and PD muscles, p-S6 was mainly overexpressed in fibers with intramuscular vacuoles containing lipid droplets (U = 0.000, P = 0.002) or basophilic materials (U = 0.000, P = 0.002).
		                        		
		                        			CONCLUSION
		                        			The mTOR pathway might be activated in myofibers with various metabolic defects, which might provide evidence for mTOR inhibition therapy in human IMMs.
		                        		
		                        		
		                        		
		                        			Adolescent
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Blotting, Western
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Child, Preschool
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Glycogen Storage Disease Type II
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunohistochemistry
		                        			;
		                        		
		                        			In Vitro Techniques
		                        			;
		                        		
		                        			Lipid Metabolism, Inborn Errors
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Mitochondrial Myopathies
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Muscular Diseases
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Signal Transduction
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			physiology
		                        			;
		                        		
		                        			TOR Serine-Threonine Kinases
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Young Adult
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail